Royal Bank of Canada’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-69
| Closed | – | – | 7447 |
|
|
2023
Q1 | $0 | Hold |
69
| – | – | ﹤0.01% | 7292 |
|
|
2022
Q4 | $0 | Sell |
69
-1
| -1% | – | ﹤0.01% | 7627 |
|
|
2022
Q3 | $0 | Hold |
70
| – | – | ﹤0.01% | 7690 |
|
|
2022
Q2 | $0 | Buy |
70
+1
| +1% | – | ﹤0.01% | 7653 |
|
|
2022
Q1 | $1K | Hold |
69
| – | – | ﹤0.01% | 7194 |
|
|
2021
Q4 | $1K | Hold |
69
| – | – | ﹤0.01% | 7064 |
|
|
2021
Q3 | $1K | Buy |
+69
| New | +$1K | ﹤0.01% | 7054 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6591 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6585 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6249 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6201 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6517 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6503 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6318 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6294 |
|
|
2017
Q4 | – | Hold |
0
| – | -$1K | – | 6349 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 5889 |
|
|
2017
Q2 | – | Hold |
0
| – | -$5K | – | 6134 |
|
|
2017
Q1 | – | Hold |
0
| – | -$9K | – | 5561 |
|
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 5370 |
|
|
2016
Q3 | – | Hold |
0
| – | -$1K | – | 5574 |
|
|
2016
Q2 | – | Hold |
0
| – | -$4K | – | 5582 |
|
|
2016
Q1 | – | Hold |
0
| – | -$4K | – | 5291 |
|
|
2015
Q4 | – | Hold |
0
| – | -$16K | – | 5474 |
|
|
2015
Q3 | – | Hold |
0
| – | -$35K | – | 5075 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4925 |
|